QIAGEN Drives The Development Of Companion Diagnostics With Two Key Appointments
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read MoreSearch Results for: lung cancer
QIAGEN Acquires Exclusive Licence for Key PI3K gene
QIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive license for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.
Read More
The Need for Molecular Diagnostics
The need for quick H1N1 assays further propels molecular to the forefront.
Read MoreComplete Genomics Sequences 14 Human Genomes for Customers
Complete Genomics Inc, a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009
Read More